200 related articles for article (PubMed ID: 8522595)
1. Constitutive expression of calreticulin in osteoblasts inhibits mineralization.
St-Arnaud R; Prud'homme J; Leung-Hagesteijn C; Dedhar S
J Cell Biol; 1995 Dec; 131(5):1351-9. PubMed ID: 8522595
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
[TBL] [Abstract][Full Text] [Related]
3. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
[TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
5. Calreticulin inhibits vitamin D3 signal transduction.
Wheeler DG; Horsford J; Michalak M; White JH; Hendy GN
Nucleic Acids Res; 1995 Aug; 23(16):3268-74. PubMed ID: 7667104
[TBL] [Abstract][Full Text] [Related]
6. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
9. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
10. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells.
Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
J Bone Miner Res; 2002 Jul; 17(7):1190-9. PubMed ID: 12096832
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the retinoic acid and retinoid X receptor signaling pathways in P19 embryonal carcinoma cells by calreticulin.
Shago M; Flock G; Leung Hagesteijn CY; Woodside M; Grinstein S; Giguère V; Dedhar S
Exp Cell Res; 1997 Jan; 230(1):50-60. PubMed ID: 9013706
[TBL] [Abstract][Full Text] [Related]
12. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
Wu Y; Craig TA; Lutz WH; Kumar R
Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
[TBL] [Abstract][Full Text] [Related]
13. Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.
Matsumoto T; Igarashi C; Takeuchi Y; Harada S; Kikuchi T; Yamato H; Ogata E
Bone; 1991; 12(1):27-32. PubMed ID: 2054233
[TBL] [Abstract][Full Text] [Related]
14. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
15. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
16. Expression of the vitamin D and the retinoid X receptors in Saccharomyces cerevisiae: alternative in vivo models for ligand-induced transactivation.
Berghöfer-Hochheimer Y; Zurek C; Langer G; Munder T
J Cell Biochem; 1997 Aug; 66(2):184-96. PubMed ID: 9213220
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D control of osteoblast function and bone extracellular matrix mineralization.
van Leeuwen JP; van Driel M; van den Bemd GJ; Pols HA
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):199-226. PubMed ID: 11693961
[TBL] [Abstract][Full Text] [Related]
18. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
Kimmel-Jehan C; Jehan F; DeLuca HF
Arch Biochem Biophys; 1997 May; 341(1):75-80. PubMed ID: 9143355
[TBL] [Abstract][Full Text] [Related]
19. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of VDR-mediated transcription by phosphorylation: correlation with increased interaction between the VDR and DRIP205, a subunit of the VDR-interacting protein coactivator complex.
Barletta F; Freedman LP; Christakos S
Mol Endocrinol; 2002 Feb; 16(2):301-14. PubMed ID: 11818502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
